Skip to content

Effect of supplements on the blood cholesterol levels -A placebo-controlled, randomized, double-blind, parallel-group comparative study-

Effect of supplements on the blood cholesterol levels -A placebo-controlled, randomized, double-blind, parallel-group comparative study- - Effect of supplements on the blood cholesterol levels

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000033875
Enrollment
80
Registered
2018-08-24
Start date
2018-08-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy person

Interventions

Test food(Intake priod:12 weeks) Placebo(Intake priod:12 weeks)

Sponsors

FANCL Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Healthy male and female aged 20 to 64 years at the time of informed consent. 2)LDL cholesterol levels>=120 mg/dl and <160 mg/dl. 3)Subjects who agree to participate in the study on one's own will.

Exclusion criteria

Exclusion criteria: 1)Subjects who are suffering or suffered from serious disease such as kidney, liver, circulatory system, malignant neoplasm, mental, dementing disorder. 2)Subjects who are suffering or suffered from alcohol abuse disorder. 3)Subjects who are receiving medication. 4)Subjects who have allergy related to the study foods. 5)Subjects who cannot stop using health foods(supplements, foods for specified health use, displayed functional foods), quasi-drugs, medicines that decrease LDL cholesterol while study term. 6)Subjects who have participated in other clinical studies within the past 3 months prior to obtaining of the informed consent, or who are planning to participate in other clinical studies during the present study. 7)Subjects who are pregnant or breast-feeding. 8)Subject who cannot stop drinking alcohol from 2 days before screening inspection and each examination. 9)Subject who are shift workers, or late night workers. 10)Subjects who have been diagnosed with familial hyperlipidemia. 11)Subjects who are judged as unsuitable for the study by the doctor and the investigator in charge for other reason.

Design outcomes

Primary

MeasureTime frame
blood LDL cholesterol levels

Secondary

MeasureTime frame
blood total cholesterol levels blood non-HDL cholesterol levels

Countries

Japan

Contacts

Public ContactEiji Yoshikawa

KSO Corporation Sales department

yoshikawa@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026